Literature DB >> 6851096

Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency.

J Siedel, E O Hägele, J Ziegenhorn, A W Wahlefeld.   

Abstract

We describe a sensitive method for quantifying the extent of cholesterol ester cleavage during enzymatic assay of total cholesterol in serum. Lipids are extracted from the assay mixture with chloroform/methanol (1/1 by vol), concentrated, then quantified by "high-performance" thin-layer chromatography. Although with conventional enzymatic reagents for determination of serum total cholesterol the hydrolysis of the cholesterol esters may be incomplete, a new enzymatic cholesterol reagent (Monotest Cholesterol, High Performance, Boehringer Mannheim) gives virtually complete cholesterol ester cleavage (i.e., greater than or equal to 99.5%). Use of this reagent with its improved lipolytic efficiency yields results for serum total cholesterol that are identical to those measured with a candidate reference procedure involving alkaline cholesterol ester saponification.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6851096

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  175 in total

1.  Demographic and cardiovascular risk factors modify association of fasting insulin with incident coronary heart disease and ischemic stroke (from the Atherosclerosis Risk In Communities Study).

Authors:  Laura J Rasmussen-Torvik; Hiroshi Yatsuya; Elizabeth Selvin; Alvaro Alonso; Aaron R Folsom
Journal:  Am J Cardiol       Date:  2010-05-15       Impact factor: 2.778

2.  On the interrelationship between hepatic carnitine, fatty acid oxidation, and triglyceride biosynthesis in nephrosis.

Authors:  A al-Shurbaji; L Berglund; R K Berge; G Cederblad; E Humble
Journal:  Lipids       Date:  1997-08       Impact factor: 1.880

3.  Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey.

Authors:  P Primatesta; N R Poulter
Journal:  BMJ       Date:  2000-11-25

4.  Incidence and risk factors for cardiovascular disease in African Americans with diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ayokanmi Adeniyi; Aaron R Folsom; Frederick L Brancati; Moise Desvorieux; James S Pankow; Herman Taylor
Journal:  J Natl Med Assoc       Date:  2002-12       Impact factor: 1.798

5.  Effect of donor islet mass on metabolic normalization in streptozotocin-diabetic rats.

Authors:  B Keymeulen; H Teng; M Vetri; F Gorus; P In't Veld; D G Pipeleers
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

6.  Risk factor associations with clinical distal symmetrical polyneuropathy and various neuropathy screening instruments and protocols in type 1 diabetes.

Authors:  G Pambianco; T Costacou; Elsa Strotmeyer; T J Orchard
Journal:  Diabetes Res Clin Pract       Date:  2010-10-28       Impact factor: 5.602

7.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

8.  Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus.

Authors:  D R Witte; S Tesfaye; N Chaturvedi; S E M Eaton; P Kempler; J H Fuller
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

9.  Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study.

Authors:  Sabita S Soedamah-Muthu; Nish Chaturvedi; John H Fuller; Monika Toeller
Journal:  Eur J Nutr       Date:  2012-12-07       Impact factor: 5.614

10.  Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study.

Authors:  Jan Bressler; Aaron R Folsom; David J Couper; Kelly A Volcik; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2009-12-02       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.